direct meds semaglutide Direct Meds

Is Retatrutide The Next Weight-Loss Breakthrough After Ozempic And Mounjaro? Here's How It Works Differently | Health and Me

Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental triple agonist that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28%

November 2025 Drug Safety: Recalls for Compounded Semaglutide, Generic Synthroid; Safety updates for Lamictal, Kineret, Miebo eye drops, Zoladex; Microneedling Injuries, more

There's a new drug in the pipeline that has the medical world paying attentionand for good reason. Retatrutide is a once-weekly injection that targets three metabolic hormones at once. The early clinical